Akers Bio offering increased

Akers Biosciences says proceeds from its offering announced on 10 January are now expected to increase to $2,147,400, gross.

Akers Bio says Joseph Gunnar & Co, the sole book-running manager for the offering, has elected to exercise the over-allotment option to purchase an additional 122,500 common shares from the company at $1.20 per share with the issuance of a further 61,250 warrants with an exercise price of $1.50.

At 9:50am: (LON:AKR) Akers Biosciences Inc share price was 0p at 127.5p